Free tool
Stocks listed on London
We cover 53 companies listed on London. The median market value in the group is $54.52M. Across the group, the median move over the past trading day is 0.00%. 38% of the 53 with a 200-day average trade above it. Price change over the past year runs from −70.9% to +69.9% across the middle 80 percent of the group, with a median of −9.5%.
Other lists in this group
Table
53 of 3,049 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| UPR.L | Uniphar plc | $1.33B | Small cap | +6.94% |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% |
| OXB.L | Oxford Biomedica plc | $847.14M | Small cap | −9.81% |
| AMS.L | Advanced Medical Solutions Group plc | $830.96M | Small cap | +38.01% |
| CRW.L | Craneware plc | $588.10M | Small cap | −40.83% |
| AGY.L | Allergy Therapeutics plc | $481.91M | Small cap | −30.00% |
| AVCT.L | Avacta Group Plc | $440.62M | Small cap | +26.36% |
| PRTC.L | PureTech Health plc | $398.28M | Small cap | −4.27% |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% |
| OPT.L | Optima Health plc | $355.51M | Small cap | +9.32% |
| IDHC.L | Integrated Diagnostics Holdings plc | $298.80M | Small cap | +16.89% |
| TSTL.L | Tristel plc | $276.02M | Small cap | +19.76% |
| DXRX.L | Diaceutics PLC | $169.64M | Small cap | +4.36% |
| EKF.L | EKF Diagnostics Holdings plc | $145.56M | Small cap | −15.56% |
| SCLP.L | Scancell Holdings plc | $136.80M | Small cap | −7.62% |
| FARN.L | Faron Pharmaceuticals Oy | $110.28M | Small cap | −79.24% |
| 4BB.L | 4basebio PLC | $99.96M | Micro cap | −46.89% |
| EAH.L | ECO Animal Health Group plc | $89.77M | Micro cap | +34.69% |
| CREO.L | Creo Medical Group PLC | $85.82M | Micro cap | −1.90% |
| POLB.L | Poolbeg Pharma PLC | $82.41M | Micro cap | +164.62% |
| OBI.L | Ondine Biomedical Inc. | $81.20M | Micro cap | −24.19% |
| KOO.L | Kooth plc | $72.00M | Micro cap | −7.59% |
| STX.L | Shield Therapeutics plc | $71.97M | Micro cap | −37.42% |
| HVO.L | hVIVO plc | $59.87M | Micro cap | −35.00% |
| BVC.L | BATM Advanced Communications Ltd. | $54.53M | Micro cap | −21.90% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | $54.52M | Micro cap | +70.43% |
| COIL.L | Coiled Therapeutics plc | $49.30M | Micro cap | −26.92% |
| MPAL.L | MedPal AI PLC | $44.20M | Micro cap | −40.00% |
| NCYT.L | Novacyt S.A. | $42.07M | Micro cap | +7.81% |
| ABDX.L | Abingdon Health Plc | $36.92M | Micro cap | +104.76% |
| PXS.L | Provexis plc | $32.52M | Micro cap | +51.39% |
| IMM.L | ImmuPharma plc | $31.75M | Micro cap | +89.66% |
| GDR.L | genedrive plc | $28.91M | Micro cap | +67.74% |
| IXI.L | IXICO plc | $23.06M | Micro cap | −36.73% |
| IHC.L | Inspiration Healthcare Group plc | $22.54M | Micro cap | −19.74% |
| CLBX.L | CelLBxHealth plc | $19.30M | Micro cap | −79.17% |
| FAB.L | Fusion Antibodies plc | $19.13M | Micro cap | −23.73% |
| THAT.L | Thalia Therapeutics Plc | $15.69M | Micro cap | +52.94% |
| GENF.L | Genflow Biosciences plc | $15.39M | Micro cap | +166.67% |
| APTA.L | Aptamer Group PLC | $15.32M | Micro cap | −62.50% |
| SVNS.L | Solvonis Therapeutics plc | $11.56M | Micro cap | −55.64% |
| GENI.L | GENinCode Plc | $9.25M | Micro cap | −35.71% |
| OPTI.L | OptiBiotix Health Plc | $7.93M | Micro cap | −51.91% |
| PRM.L | Proteome Sciences plc | $7.53M | Micro cap | −44.39% |
| OBD.L | Oxford BioDynamics Plc | $6.85M | Micro cap | −74.11% |
| NFX.L | Nuformix plc | $5.85M | Micro cap | +80.68% |
| PYC.L | Physiomics Plc | $3.17M | Micro cap | +21.18% |
| FUM.L | Futura Medical plc | $3.16M | Micro cap | −95.67% |
| BSFA.L | BSF Enterprise Plc | $3.03M | Micro cap | −48.89% |
| VAL.L | ValiRx plc | $2.78M | Micro cap | −73.04% |
| IBAI.L | Imaging Biometrics Ltd. | $2.35M | Micro cap | +2.42% |
| TRLS.L | Trellus Health plc | $701.41K | Micro cap | −94.29% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.